18F-FDG PET 绘制儿童药物敏感性与药物难治性癫痫患者脑葡萄糖代谢特征
这项回顾性研究纳入40例儿童癫痫患者(药物敏感组22例、药物难治组18例)和25例对照,所有患者接受至少间隔一年的两次18F-FDG PET扫描。药物敏感组在基线和随访时的绝对不对称指数均低于药物难治组,难治组表现为更广泛且进展性的低代谢及脑网络连接效率下降。
要点
- 药物敏感组基线(P=0.038)和随访(P=0.003)的绝对不对称指数均低于药物难治组。
- 两组基线和随访均存在低代谢,药物难治组低代谢范围更广且随访时加重。
- 药物难治组全局效率、平均度、聚类系数较低,特征路径长度较长。
核心结论
- 研究首次在体内揭示了接受抗癫痫药物治疗的非手术儿童癫痫患者的脑葡萄糖代谢模式。
- 与药物敏感组相比,药物难治性癫痫患者表现为显著更广泛且进展性的低代谢以及低效的脑网络连接。
- 18F-FDG PET显像可能是癫痫患者诊疗一体化的一种潜在可视化方法。
研究设计与样本
- 回顾性研究,纳入40例患者和25例对照。
- 患者根据随访时癫痫发作频率分为药物敏感组(n=22)和药物难治组(n=18)。
- 所有患者接受两次18F-FDG PET扫描,间隔至少一年。
- 计算绝对不对称指数评估代谢差异及癫痫灶变化,使用统计参数图进行全脑体素水平分析,基于图论进行网络分析。
主要发现
- 药物敏感组基线绝对不对称指数低于药物难治组(P=0.038),随访时亦低于药物难治组(P=0.003)。
- 药物敏感组绝对不对称指数在两次扫描间下降,药物难治组上升,但趋势均未达统计学显著(P=0.240和P=0.450)。
- 两组基线均表现为低代谢;药物敏感组低代谢脑区少于药物难治组。
- 药物敏感组两次扫描间低代谢水平保持稳定,药物难治组低代谢增加。
- 网络分析显示药物敏感组全局效率、平均度和聚类系数高于药物难治组,特征路径长度短于药物难治组。
关键数值与推荐
- 药物敏感组基线绝对不对称指数低于药物难治组(P=0.038)。
- 药物敏感组随访绝对不对称指数低于药物难治组(P=0.003)。
- 药物敏感组绝对不对称指数变化趋势P=0.240,药物难治组P=0.450。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to investigate [18F]fluorodeoxyglucose positron emission tomography ([18F]FDG PET) mapping for cerebral glucose metabolism in drug-sensitive and drug-resistant pediatric epilepsy patients. METHODS: This retrospective study enrolled 40 patients and 25 controls. Patients were categorized into drug-sensitive epilepsy (n = 22) and drug-resistant epilepsy (n = 18) according to the seizure frequency at follow-up. All patients underwent two [18F]FDG PET scans separated by a minimum of one year. Absolute asymmetry index (|AI|) was calculated for assessing metabolic differences and changes in epileptic foci. Statistical Parametric Mapping (SPM) was utilized to reveal voxel-wise metabolic characteristics and alterations throughout the brain. Network analysis based on graph theory was used to investigate network-level differences between the two patient groups. RESULTS: The drug-sensitive group showed a lower |AI| at both baseline (P = 0.038) and follow-up (P = 0.003) PET scans than the drug-resistant group. |AI| decreased in the drug-sensitive group and increased in the drug-resistant group across scans, but these trends were not statistically significant (P = 0.240 and P = 0.450, respectively). Both groups exhibited hypometabolism at baseline. The drug-sensitive group showed less hypometabolic brain regions than the drug-resistant group. The drug-sensitive maintained stable level of hypometabolism between the two scans, whereas the drug-resistant group showed an increasing hypometabolism. Network analysis demonstrated that the drug-sensitive group had a higher global efficiency, average degree, and clustering, along with a shorter characteristic path length compared to the drug-resistant group. CONCLUSIONS: For the first time, this study revealed in vivo cerebral glucose metabolic pattern of nonsurgical pediatric epilepsy patients treated by antiepileptic drugs. Especially, drug-resistant epilepsy patients represented significantly extensive and progressive hypometabolism with inefficient brain network connectivity compared with drug-sensitive epilepsy. [18F]FDG PET imaging may be a potential visual approach for theranostics of epilepsy patients.
引用
- Hu D, Yu C, Zhang X, et al. [18F]FDG PET for mapping the cerebral glucose metabolic characteristics of drug-sensitive and drug-resistant epilepsy in pediatric patients. Eur J Nucl Med Mol Imaging. 2024. PMID: 39373899. doi:10.1007/s00259-024-06933-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。